Home > Insider Trading > Filing (0001179110-15-009972)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
792977	Amag Pharmaceuticals Inc.	AMAG	Pharmaceutical Preparations (2834)	042742593

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1537670	A Scott Holmes	C/O Amag Pharmaceuticals, Inc. 1100 Winter Street Waltham MA 02451	Svp, Finance And Treasurer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2015-06-15	1,346	$66.63	51,958	No	4	S	Direct
Common Stock	Acquisiton	2015-06-15	2,734	$14.89	54,692	No	4	M	Direct
Common Stock	Acquisiton	2015-06-15	3,500	$16.55	58,192	No	4	M	Direct
Common Stock	Disposition	2015-06-15	6,234	$66.63	51,958	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2015-06-15	2,734	$0.00	2,734	$14.89
Common Stock	Stock Option (Right to Buy)	Acquisiton	2015-06-15	3,500	$0.00	3,500	$16.55

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
14,375		2019-06-25	No	4	M	Direct
11,500		2023-02-28	No	4	M	Direct

Footnotes

The reported transactions on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 4, 2015.
This option vests and becomes exercisable over four years from the grant date (June 25, 2012), with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal quarterly installments over the next three years thereafter.
This option vests and becomes exercisable over four years from the grant date (February 28, 2013), with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal quarterly installments over the next three years thereafter.